PDE-4 inhibitors have previously been shown to increase synaptic plasticity via the cAMP/PKA/CREB signal pathway and restore cognitive impairments (Kelly 2018; Schreiber et al. 2020). Here, PDE4A is linked to Cognitive impairment.